LLY

1,040.97

+2.7%↑

JNJ

231.49

+0.92%↑

ABBV

214.52

+0.83%↑

UNH

382.43

-0.24%↓

AZN

189.76

+1.28%↑

LLY

1,040.97

+2.7%↑

JNJ

231.49

+0.92%↑

ABBV

214.52

+0.83%↑

UNH

382.43

-0.24%↓

AZN

189.76

+1.28%↑

LLY

1,040.97

+2.7%↑

JNJ

231.49

+0.92%↑

ABBV

214.52

+0.83%↑

UNH

382.43

-0.24%↓

AZN

189.76

+1.28%↑

LLY

1,040.97

+2.7%↑

JNJ

231.49

+0.92%↑

ABBV

214.52

+0.83%↑

UNH

382.43

-0.24%↓

AZN

189.76

+1.28%↑

LLY

1,040.97

+2.7%↑

JNJ

231.49

+0.92%↑

ABBV

214.52

+0.83%↑

UNH

382.43

-0.24%↓

AZN

189.76

+1.28%↑

Strona główna・Stock List・Medtronic PLC
Search

Medtronic PLC

Closed

SectorHealthcare

78.11 0.13

Buy

Price update 21 maj 2026, 19:59 UTC

BuySell

Overview

Share price change

24h

Current

Min

76.81

Max

78.11

Key metrics

By Trading Economics

Income

-231M

1.1B

Sales

57M

9B

P/E

Sector Avg

21.598

49.701

EPS

0.89

Dividend yield

3.72

Profit margin

12.675

Employees

95,000

EBITDA

124M

2.5B

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+35.04% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

3.72%

2.39%

Next Earnings

3 cze 2026

Next Dividend date

10 lip 2026

Next Ex Dividend date

26 cze 2026

Market Stats

By TradingEconomics

Market Cap

-28B

99B

Previous open

77.98

Previous close

78.11

News Sentiment

By Acuity

31%

69%

73 / 345 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Weak Bearish Evidence

83.26 / 84.875 Support & Resistance

Medtronic PLC Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

20 maj 2026, 13:49 UTC

Acquisitions, Mergers, Takeovers

Medtronic to Buy SPR Therapeutics for About $650 Million

DJ

Read

10 mar 2026, 11:19 UTC

Acquisitions, Mergers, Takeovers

Medtronic to Buy Scientia Vascular in $550 Million Deal

DJ

Read

17 lut 2026, 12:43 UTC

Earnings

Medtronic 3Q Profit Falls Despite Higher Revenue

DJ

Read

20 maj 2026, 13:15 UTC

Acquisitions, Mergers, Takeovers

Medtronic Announces Intent To Acquire SPR Therapeutics, Inc., Expanding Care Options For People Living With Chronic Pain >MDT

DJ

Read

20 maj 2026, 13:15 UTC

Acquisitions, Mergers, Takeovers

Medtronic to Buy SPR Therapeutics for About $650 Million in Cash >MDT

DJ

Read

22 kwi 2026, 11:27 UTC

Earnings

Intuitive Surgical Earnings Show Big Beats Don't Always Spark Stock Rallies -- Barrons.com

DJ

Read

20 kwi 2026, 11:50 UTC

Acquisitions, Mergers, Takeovers

Medtronic Completes Acquisition Of CathWorks, Expanding Its Leadership In Transforming Care For Patients With Cardiovascular Disease >MDT

DJ

Read

24 mar 2026, 20:59 UTC

Earnings

Medtronic PLC Cuts FY26 View To Adj EPS $5.50-Adj EPS $5.54 >MDT

DJ

Read

10 mar 2026, 10:46 UTC

Acquisitions, Mergers, Takeovers

Medtronic: Scientia Deal Complements Neurovascular Portfolio >MDT

DJ

Read

10 mar 2026, 10:46 UTC

Acquisitions, Mergers, Takeovers

Medtronic: Scientia Deal Includes Potential Undisclosed Earn-Out, Milestone Payments >MDT

DJ

Read

10 mar 2026, 10:45 UTC

Acquisitions, Mergers, Takeovers

Medtronic: Scientia Vascular Acquisition Valued at $550 Million >MDT

DJ

Read

10 mar 2026, 10:45 UTC

Acquisitions, Mergers, Takeovers

Medtronic to Acquire Scientia Vascular >MDT

DJ

Read

17 lut 2026, 21:21 UTC

Earnings

These Stocks Are Today's Movers: Paramount, Masimo, Medtronic, Kyndryl, eToro, Genuine Parts, Southwest, and More -- Barrons.com

DJ

Read

17 lut 2026, 18:11 UTC

Earnings

Medtronic Posts Better-Than-Expected Earnings. Here's Why the Stock Is Falling. -- Barrons.com

DJ

Read

17 lut 2026, 14:48 UTC

Earnings

Medtronic Posts Better-Than-Expected Earnings. Here's Why the Stock Is Falling. -- Barrons.com

DJ

Read

17 lut 2026, 13:00 UTC

Earnings

Medtronic Posts Better-Than-Expected Earnings. Here's Why the Stock Is Falling. -- Barrons.com

DJ

Read

17 lut 2026, 12:05 UTC

Earnings

Medtronic Posts Better-Than-Expected Earnings. Here's Why the Stock Is Falling. -- Barrons.com

DJ

Read

17 lut 2026, 11:47 UTC

Earnings

Medtronic Sees 2026 EPS up 4.5%, Excluding Potential Impact From Tariffs >MDT

DJ

Read

17 lut 2026, 11:47 UTC

Earnings

Medtronic Still Sees FY26 Organic Revenue Up About 5.5% >MDT

DJ

Read

17 lut 2026, 11:46 UTC

Earnings

Medtronic FY26 View Includes Potential Impact From Tariffs of About $185M >MDT

DJ

Read

17 lut 2026, 11:46 UTC

Earnings

Medtronic Backs FY26 View of Adj EPS $5.62-Adj EPS $5.66 >MDT

DJ

Read

17 lut 2026, 11:46 UTC

Earnings

Medtronic Reiterates FY26 Organic Rev Growth, EPS Guidance >MDT

DJ

Read

17 lut 2026, 11:45 UTC

Earnings

Medtronic 3Q Adj EPS $1.36 >MDT

DJ

Read

17 lut 2026, 11:45 UTC

Earnings

Medtronic 3Q Neuroscience Portfolio Rev $2.56B >MDT

DJ

Read

17 lut 2026, 11:45 UTC

Earnings

Medtronic 3Q Organic Revenue Up 6.0% >MDT

DJ

Read

17 lut 2026, 11:45 UTC

Earnings

Medtronic 3Q Sales $9.02B >MDT

DJ

Read

17 lut 2026, 11:45 UTC

Earnings

Medtronic 3Q Diabetes Rev $796M >MDT

DJ

Read

17 lut 2026, 11:45 UTC

Earnings

Medtronic 3Q Cardiovascular Portfolio Rev $3.46B >MDT

DJ

Read

17 lut 2026, 11:45 UTC

Earnings

Medtronic 3Q Medical Surgical Portfolio Rev $2.17B >MDT

DJ

Read

17 lut 2026, 11:45 UTC

Earnings

Medtronic 3Q Net $1.14B >MDT

DJ

Read

Peer Comparison

Price change

Medtronic PLC Forecast

Price Target

By TipRanks

35.04% upside

12 Months Forecast

Average 105.53 USD  35.04%

High 120 USD

Low 86 USD

Based on 17 Wall Street analysts offering 12 month price targets forMedtronic PLC - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

17 ratings

11

Buy

6

Hold

0

Sell

Based on 17 analysts giving stock ratings to Medtronic PLC - Dist in the past 3 months.

Technical Score

By Trading Central

83.26 / 84.875Support & Resistance

Short Term

Weak Bearish Evidence

Recent bearish events outweigh bullish events.

Intermediate Term

Bullish Evidence

All events are bullish.

Long Term

Bearish Evidence

All events are bearish.

Sentiment

By Acuity

73 / 345 Ranking in Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Medtronic PLC

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. The segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists; and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat other non-exclusive diseases and conditions; and patient monitoring and airway management products. The Diabetes Operating Unit segment provides insulin pumps and consumables, continuous glucose monitoring systems, and InPen, a smart insulin pen system. The company was founded in 1949 and is headquartered in Galway, Ireland.

Other stocks from the sector

LLY

Eli Lilly and Co.

1,040.97

↑ +2.7%

JNJ

Johnson and Johnson

231.49

↑ +0.92%

ABBV

AbbVie Inc

214.52

↑ +0.83%

UNH

UnitedHealth Group Inc

382.43

↓-0.24%

AZN

AstraZeneca PLC

189.76

↑ +1.28%
help-icon Live chat